Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL4556637

Cc1ccc(-c2cc(CCC(=O)NCCc3ccccn3)nc(C#N)n2)cc1C.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 10/20 0.47
KCNH2 Q12809 6/20 0.46
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CTSS P25774 3/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PKM P14618 1/20 0.41
EGLN1 Q9GZT9 4/20 0.40
CTSL P07711 2/20 0.40
CTSB P07858 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4442684 0.77 CTSK (0.52) CTSKKCNH2CTSSALDH1A1MAPT
SCHEMBL4444112 0.75 CTSK (0.53) CTSKKCNH2KMT2AMEN1CTSS
Hydrochloric Acid SCHEMBL4442376 0.70 CTSK (0.67) CTSKKCNH2CTSSCTSLCTSB
Trifluoroacetic Acid SCHEMBL3881048 0.68 CTSK (0.64) CTSKKCNH2CTSSCTSLCTSB
Trifluoroacetic Acid SCHEMBL4557231 0.68 CTSK (0.57) CTSKKCNH2CTSSCTSLCTSB
Trifluoroacetic Acid SCHEMBL4451974 0.68 CTSK (0.53) CTSKKCNH2CTSSCTSLCTSB
SCHEMBL4444486 0.67 CTSK (0.58) CTSKKCNH2CTSSCTSLCTSB
SCHEMBL5548728 0.67 CTSK (0.61) CTSKKCNH2CTSSCTSLCTSB
SCHEMBL4444488 0.67 CTSK (1.00) CTSKCTSS
Trifluoroacetic Acid SCHEMBL4452052 0.66 CTSK (0.53) CTSKKCNH2CTSSCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 CTSK 1852/4885KCNH2 2293/4885KMT2A 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.